$NOVO B (+3,6 %) announcement about a partnership with OpenIA, is like a beatifull song for the market ears. But unfortunately not a meaningful news because all major Pharmas are already using IA in research and supply chains
"
* Novo Nordisk entered strategic partnership with OpenAI to deploy
advanced AI across drug discovery, manufacturing, supply chain, distribution,
and commercial operations.
* Collaboration targets faster identification of drug candidates through
analysis of complex datasets, aiming to shorten timelines from research to
patient delivery.
* Agreement includes workforce upskilling to raise AI literacy across
Novo Nordisk’s global organization.
* Partnership uses strict data governance and human oversight to support
ethical, compliant use of AI.
* Pilot programs start across R&D, manufacturing, and commercial
operations, with full integration targeted by end-2026.
(C) Copyright 2026 - Public Technologies (PUBT)"
